Bliss GVS Pharma

673.10
+31.55
(4.92%)
Market Cap
₹7,153.39 Cr
PE Ratio
41.00
Volume
4,09,170
Day High - Low
₹673.60 - ₹621.55
52W High-Low
₹739.90 - ₹140.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
7,153.39 Cr
EPS
12.23
PE Ratio
41.00
PB Ratio
5.29
Book Value
121.29
EBITDA
237.60
Dividend Yield
0.23 %
Return on Equity
10.94
Debt to Equity
0.05
Forecast For
Actual
Performance
Market Today
673.10marker-dot
Today's Low
621.554.92%
Today's High
673.604.92%
Historical Performance
673.10marker-dot
52 Week's Low
140.80318.93%
52 Week's High
739.90318.93%
Open637.00
High673.60
Low621.55
Prev. Close641.55
Volume4,09,170
Avg Price652.66
Lower Circuit639.45
Upper Circuit706.75
1-Year High739.90
1-Year Low140.80
3-Year High739.90
3-Year Low92.15
5-Year High739.90
5-Year Low66.10

Company News

View All News
Caret
negative
Bliss GVS Pharma Limited paid fines totaling ₹3.6 lakh to BSE and NSE for non-compliance with board composition rules, specifically failing to appoint a woman director.
positive
Bliss GVS Pharma's UK subsidiary, Asterisk Lifesciences, secured MHRA marketing authorization for Mesalazine 1g Suppositories, expanding its regulatory footprint in the United Kingdom.
positive
Bliss GVS Pharma reported a standalone net profit of ₹7,356.54 lakh for Q2FY27, up 196% YoY. Revenue from operations rose 37% to ₹26,112.98 lakh.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,880.00
#1 4,51,074.97
41.20
#1 61,673.90
12.69
#1 11,565
-36.16
63.60
11,442.00
3,03,749.15
90.40
11,067.00
13.95
2,568
63.57
78.53
4,670.00
1,77,631.79
85.50
13,886.20
20.34
2,138
-9.64
47.27
2,424.00
1,30,971.68
97.10
6,867.80
22.01
890
#1 124.27
69.60
1,189.90
1,18,692.98
28.00
27,657.90
17.64
5,026
-25.10
52.34
1,380.00
1,15,185.88
42.00
35,058.60
3.90
4,158
-31.69
70.24
1,391.80
1,12,437.74
39.90
29,044.60
2.24
3,870
-37.08
54.92
2,640.00
1,09,043.90
48.10
14,636.40
14.85
1,938
37.66
65.43
1,823.20
1,04,902.90
26.00
34,145.20
5.56
3,503
32.51
66.06
1,980.30
90,557.13
#1 17.60
29,038.90
#1 26.75
5,356
-22.19
44.92
Growth Rate
Revenue Growth
18.25 %
Net Income Growth
49.17 %
Cash Flow Change
30.98 %
ROE
32.29 %
ROCE
35.36 %
EBITDA Margin (Avg.)
23.13 %

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
14 Sept 2021 DIVIDEND Dividend
₹ 0.50 /share
13 Sept 2021 122.40 110.50
21 Jun 2022 DIVIDEND Dividend
₹ 0.50 /share
20 Jun 2022 80.40 72.15
28 Jun 2022 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Jun 2022 80.40 75.10
13 Jul 2023 DIVIDEND Dividend
₹ 0.50 /share
12 Jul 2023 82.15 82.95
19 Jul 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Jul 2023 83.76 101.70
19 Jul 2024 DIVIDEND Dividend
₹ 0.50 /share
18 Jul 2024 123.60 111.29
25 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Jul 2024 123.60 121.20
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Oct 2024 127.93 126.75
28 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jan 2025 173.80 150.79
12 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 May 2025 117.80 111.84
24 Jul 2025 DIVIDEND Dividend
₹ 0.50 /share
24 Jul 2025 111.84 156.90
29 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Jul 2025 161.90 155.11
31 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Jul 2025 111.84 183.17
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2025 152.04 153.85
10 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2026 172.77 203.75
18 Feb 2026 DIVIDEND Dividend
₹ 0.50 /share
18 Feb 2026 203.75 231.45
12 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 May 2026 274.40 272.15
08 Jul 2026 DIVIDEND Dividend
₹ 1.00 /share
08 Jul 2026 272.15 511.55
15 Jul 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
15 Jul 2026 272.15 521.10
12 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2026 488.95 494.05
29 Oct 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Oct 2026 612.10 650.05

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.27%
0
0.00%
-0.02%
Union Active Momentum Fund Direct-Growth
0.00%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
56.10
ATR(14)
Volatile
34.19
STOCH(9,6)
Neutral
63.71
STOCH RSI(14)
Neutral
72.97
MACD(12,26)
Bullish
3.74
ADX(14)
Weak Trend
16.73
UO
Bearish
66.41
ROC
Uptrend And Accelerating
3.79
WillR
Overbought
-8.15